Trial Profile
Effect of the GLP1 receptor agonist ( Exenatide ) on Content intramyocardial triglyceride levels in diabetic obese patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Glimepiride (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 08 Dec 2015 New trial record